Clinical outcome of combination of vancomycin and ceftaroline versus vancomycin monotherapy for treatment of methicillin resistant Staphylococcus aureus bloodstream infection
The results of this study are limited by a retrospective observational design; however, combination of vancomycin and ceftaroline for MRSA bacteraemia was not associated with lower bacteraemia recurrence or mortality compared to vancomycin monotherapy.
Authors
- Nicholas J. Mercuro (ORCID: https://orcid.org/0000-0001-7619-8736)
- Kristina Rokas
- Rami Waked (ORCID: https://orcid.org/0000-0001-8280-6638)
- Daniel J. Diekema (ORCID: https://orcid.org/0000-0003-1273-0724)
- Christina Yen (ORCID: https://orcid.org/0000-0002-6145-4693)
- Emily Wood (ORCID: https://orcid.org/0000-0002-1466-5615)
- Leslie Coats
- Adriana E. Rosato (ORCID: https://orcid.org/0000-0001-6115-6955)
Institutions
- MaineHealth (US)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1186/s12879-024-10107-7
- Citations
- 3
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 1.17